Amylyx Pharmaceuticals, Inc. (AMLX)
27.79
-0.29
(-1.03%)
USD |
NASDAQ |
Oct 02, 16:00
27.80
+0.01
(+0.04%)
After-Hours: 20:00
Amylyx Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -147.6% |
| June 30, 2024 | |
| March 31, 2024 | -31.68% |
| December 31, 2023 | 91.09% |
| September 30, 2023 | 94.62% |
| June 30, 2023 | 94.03% |
| March 31, 2023 | 92.32% |
| December 31, 2022 | 86.28% |
| Date | Value |
|---|---|
| September 30, 2022 | 2.32% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | 96.49% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 62.94% |
| Eli Lilly & Co. | 85.78% |
| Merck & Co., Inc. | 71.51% |
| EyePoint, Inc. | -36.09% |
| Bristol Myers Squibb Co. | 67.95% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.72% |
| Return on Assets | -52.46% |
| Return on Invested Capital | -56.49% |
| Return on Net Operating Assets | -2.74K% |